Literature DB >> 2164503

A mortality study of a cohort of slate quarry workers in the German Democratic Republic.

W H Mehnert1, W Staneczek, M Möhner, G Konetzke, W Müller, W Ahlendorf, B Beck, R Winkelmann, L Simonato.   

Abstract

Following reports from other countries indicating an excess risk of lung cancer among silicotics, a historical cohort of workers employed for at least one year at a company in charge of slate extraction and processing during the period 1953-1985 in the German Democratic Republic has been constructed and followed up for mortality from 1970 to 1985. The results of the study show a mortality excess for infectious and respiratory diseases. The overall lung cancer mortality is not in excess but shows a tendency to increase with time since first exposure. A mortality excess from lung cancer is concentrated among workers receiving compensation for silicosis, suggesting a possible carcinogenic risk for individuals suffering from this pathological condition.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164503

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN: 0300-5038


  4 in total

1.  Silica dust and lung cancer in the German stone, quarrying, and ceramics industries: results of a case-control study.

Authors:  K Ulm; B Waschulzik; H Ehnes; K Guldner; B Thomasson; A Schwebig; H Nuss
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Mortality among workers in the diatomaceous earth industry.

Authors:  H Checkoway; N J Heyer; P A Demers; N E Breslow
Journal:  Br J Ind Med       Date:  1993-07

3.  Silica, silicosis and lung-cancer: results from a cohort study in the stone and quarry industry.

Authors:  K Ulm; P Gerein; J Eigenthaler; S Schmidt; H Ehnes
Journal:  Int Arch Occup Environ Health       Date:  2004-05-20       Impact factor: 3.015

4.  Occupational exposure to silica dust and risk of lung cancer: an updated meta-analysis of epidemiological studies.

Authors:  Satiavani Poinen-Rughooputh; Mahesh Shumsher Rughooputh; Yanjun Guo; Yi Rong; Weihong Chen
Journal:  BMC Public Health       Date:  2016-11-04       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.